Infantile chronic recurrent parotitis (ICRP) is an insidious disease whose etiopathogenesis remains an enigma. Alterations in the physical appearance of parotid saliva from ICRP patients have been ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) ...
CHICAGO — Positive phase 3 trials for two drugs, telitacicept and ianalumab, showed promise for offering systemic treatment for Sjögren disease, rather than only symptom control. Findings of both ...
THE ECHO viruses, though recognized only recently, are clearly capable of producing a varied spectrum of clinical illness. Melnick and Sabin, 1 in observations based on recent epidemic outbreaks of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback